PNC-27

Research

3Vendors

An experimental anti-cancer peptide studied for selectively lysing tumor cells. This is not a mainstream wellness compound; discussion is sparse and mostly tied to oncology research interest.

View Vendors

Studies
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes.	PubMed
Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer.	PubMed
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide.	PubMed

PNC-27 Vendors
Ion Peptides 0.0	Profile
Peptidology 0.0	Profile
Southern Aminos 0.0	Profile

PNC-27 Vendors